Diagonal Bio AB (publ) (NGM:DIABIO)
Sweden · Delayed Price · Currency is SEK 0.0050
0.00 (0.00%)
At close: Nov 7, 2025
Diagonal Bio AB Market Cap
Diagonal Bio AB has a market cap or net worth of 8.17 million as of November 7, 2025. Its market cap has decreased by -48.63% in one year.
Market Cap
8.17M
Enterprise Value
6.43M
Revenue
1.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since July 16, 2021, Diagonal Bio AB's market cap has decreased from 139.06M to 8.17M, a decrease of -94.12%. That is a compound annual growth rate of -48.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 8.17M | 22.85% |
| Dec 30, 2024 | 6.65M | -52.86% |
| Dec 29, 2023 | 14.11M | 40.22% |
| Dec 30, 2022 | 10.06M | -87.72% |
| Dec 30, 2021 | 81.97M | -41.05% |
| Jul 16, 2021 | 139.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 112.36B |
| Getinge AB | 59.19B |
| Sectra AB | 56.72B |
| Medicover AB | 35.40B |
| Asker Healthcare Group AB | 34.62B |
| Camurus AB | 32.49B |
| BioArctic AB | 23.36B |
| AddLife AB | 22.59B |